P&U Predicts Fourth Quarter Launch For "Approvable" Antidepressant Vestra
Executive Summary
Pharmacia & Upjohn and co-promotion partner Janssen expect a fourth quarter launch for the antidepressant Vestra (reboxetine), following FDA "approvable" designation July 29.